Copertina

Toward a more patient‐centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Fabio Efficace, Rena Buckstein, Gregory A. Abel, Johannes M. Giesinger, Pierre Fenaux, Jan Philipp Bewersdorf, Andrew M. Brunner, Rafael Bejar, Uma Borate, Amy E. DeZern, Peter Greenberg, Gail J. Roboz, Michael R. Savona, Francesco Sparano, Jacqueline Boultwood, Rami Komrokji, David A. Sallman, Zhuoer Xie, Guillermo Sanz, Hetty E. Carraway, Justin Taylor, Stephen D. Nimer, Matteo Giovanni Della Porta, Valeria Santini, Maximilian Stahl, Uwe Platzbecker, Mikkael A. Sekeres, Amer M. Zeidan
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	HemaSphere
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Long‐term follow‐up and combined Phase 2 results of eprenetapopt and azacitidine in patients with TP53 mutant MDS/AML
di: David A. Sallman, et al.
Pubblicazione: (2025)

On the Direct Construction of MDS and Near-MDS Matrices
di: Gupta, Kishan Chand, et al.
Pubblicazione: (2023)

Construction of all MDS and involutory MDS matrices
di: Kumar, Yogesh, et al.
Pubblicazione: (2024)

A note on cyclic MDS and non-MDS matrices
di: Chatterjee, Tapas, et al.
Pubblicazione: (2024)

Generalized GM-MDS: Polynomial Codes are Higher Order MDS
di: Brakensiek, Joshua, et al.
Pubblicazione: (2023)

Near MDS and near quantum MDS codes via orthogonal arrays
di: Pang, Shanqi, et al.
Pubblicazione: (2023)

Distinctive Molecular Risk Factors Between MDS and MDS / AML Defined by ICC
di: Ting‐juan Zhang, et al.
Pubblicazione: (2026)

Improved Decoding Algorithms for MDS and Almost-MDS Codesfrom Twisted GRS Codes
di: Wang, Guodong, et al.
Pubblicazione: (2025)

Validation of the diagnostic potential of 17 immunophenotypic core markers defined by the ELN‐iMDS‐Flow Working Group in an independent cohort of patients with MDS
di: Coen R. Veenstra, et al.
Pubblicazione: (2025)

MDS Stabilizer Poset Codes
di: Can, Mahir Bilen
Pubblicazione: (2024)

On the Counting of Involutory MDS Matrices
di: Samanta, Susanta
Pubblicazione: (2023)

Metric/Nonmetric Elastic MDS
di: de Leeuw, Jan
Pubblicazione: (2025)

MDS Generalized Convertible Code
di: Ge, Songping, et al.
Pubblicazione: (2024)

Analysis of DBS Outcome by MDS ‐ UPDRS Severity Levels: Comparison with Changes on MDS ‐ UPDRS III
di: Sergio A. Castillo‐Torres, et al.
Pubblicazione: (2025)

Independent confirmation of the immunophenotypic ELN Scoring System in patients with MDS and CMML
di: Uta Oelschlaegel, et al.
Pubblicazione: (2025)

High levels of global hydroxymethylation predict worse overall survival in MDS patients treated with azacitidine
di: Francesca Tiso, et al.
Pubblicazione: (2025)

Reply to Letter to the Editor‐MDS‐23‐0498.R2/MDS‐24‐0318.R1
di: Christopher Kruse, et al.
Pubblicazione: (2024)

MDS, Hermitian Almost MDS, and Gilbert-Varshamov Quantum Codes from Generalized Monomial-Cartesian Codes
di: Barbero-Lucas, Beatriz, et al.
Pubblicazione: (2023)

Treatment Patterns and Outcomes of Patients With Myelodysplastic Syndrome (MDS) by IPSS‐R Scores at Academic Cancer Centers
di: Connor Willis, et al.
Pubblicazione: (2025)

On the Maximal Length of MDS Elliptic Codes
di: Chen, Haojie, et al.
Pubblicazione: (2026)

Embedding in MDS codes and Latin cubes
di: Potapov, Vladimir N.
Pubblicazione: (2021)

On MDS Property of g-Circulant Matrices
di: Chatterjee, Tapas, et al.
Pubblicazione: (2024)

On additive MDS codes with linear projections
di: Adriaensen, Sam, et al.
Pubblicazione: (2022)

The Entropy Characterization of Quantum MDS Codes
di: Sun, Hua
Pubblicazione: (2025)

On the construction of ultra-light MDS matrices
di: Tian, Yu, et al.
Pubblicazione: (2024)

Not all Tregs in MDS are created equal
di: Mischa Selig, et al.
Pubblicazione: (2026)

On MDS Convertible Codes in the Merge Regime
di: Ramkumar, Vinayak, et al.
Pubblicazione: (2025)

On the generalization of $g$-circulant MDS matrices
di: Khan, Atif Ahmad, et al.
Pubblicazione: (2026)

Prevalence of massively diluted bone marrow cell samples aspirated from patients with myelodysplastic syndromes (MDS) or suspected of MDS: A retrospective analysis of nationwide samples in Japan
di: Kiyoyuki Ogata, et al.
Pubblicazione: (2024)

Response to luspatercept can be predicted and improves overall survival in the real‐life treatment of LR‐MDS
di: Angela Consagra, et al.
Pubblicazione: (2025)

A note on MDS Property of Circulant Matrices
di: Chatterjee, Tapas, et al.
Pubblicazione: (2024)

Egoistic MDS-based Rigid Body Localization
di: Führling, Niclas, et al.
Pubblicazione: (2025)

MDS-DETR: DETR with Masked Duplicate Suppressor
di: Lee, Chanho, et al.
Pubblicazione: (2026)

Some MDS codes over dihedral groups
di: Wang, Yuchao
Pubblicazione: (2025)

A Characterization of Semi-Involutory MDS Matrices
di: Chatterjee, Tapas, et al.
Pubblicazione: (2024)

New Insights into Involutory and Orthogonal MDS Matrices
di: Kumar, Yogesh, et al.
Pubblicazione: (2025)

A characterization for an almost MDS code to be a near MDS code and a proof of the Geng-Yang-Zhang-Zhou conjecture
di: Qiang, Shiyuan, et al.
Pubblicazione: (2024)

Clinical outcomes and safety in patients with lower‐risk myelodysplastic syndromes treated with imetelstat: Substudy of the phase 3 IMerge trial
di: Rami S. Komrokji, et al.
Pubblicazione: (2025)

Correction to “Cytidine deaminase status as a marker of response to azacytidine treatment in MDS and AML patients”
Pubblicazione: (2024)

Designing High-Order Lightweight Circulant MDS Matrices
di: Dr. Xiaoyan Chen, et al.
Pubblicazione: (2021)